X

Astrazeneca Pharma India Ltd Q2FY24; 58% rise in Profits

AstraZeneca Pharma India Ltd is engaged in the business of manufacture, distribution and marketing of pharmaceutical products.

Financial Results:

Astrazeneca Pharma India Ltd reported Revenues for Q2FY24 of ₹311.00 Crores up from ₹236.00 Crore year on year, a rise of 31.78%.

Total Expenses for Q2FY24 of ₹262.00 Crores up from ₹198.00 Crores year on year, a rise of 32.32%.

Consolidated Net Profit of ₹52.00 Crores up 57.58% from ₹33.00 Crores in the same quarter of the previous year.

The Earnings per Share is ₹20.95, up 60.91% from ₹13.02 in the same quarter of the previous year.

*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.

*The presented data is automatically generated. It may occasionally generate incorrect information.

Related Post